title: Future oversight of recombinant DNA research: recommendations of an Institute of Medicine committee.
authors.affiliation: O'Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, DC.
authors.forename: Lawrence O
authors.initials: LO
authors.lastname: Gostin
authors.affiliation: Board on Health Sciences Policy, Institute of Medicine, Washington, DC.
authors.forename: Bruce M
authors.initials: BM
authors.lastname: Altevogt
authors.affiliation: Board on Health Sciences Policy, Institute of Medicine, Washington, DC.
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Pope
mesh_terms: D026683:Advisory Committees; D035843:Biomedical Research / Q000941:ethics / Q000592:standards*; D002986:Clinical Trials as Topic; D004274:DNA, Recombinant / Q000009:adverse effects*; D018014:Gene Transfer Techniques / Q000009:adverse effects* / Q000941:ethics; D015316:Genetic Therapy / Q000009:adverse effects* / Q000941:ethics; D006805:Human Experimentation; D006801:Humans; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D009316:National Institutes of Health (U.S.); D061214:Patient Safety; D014481:United States
chemical_list: D004274:DNA, Recombinant